69 related articles for article (PubMed ID: 1840198)
1. Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor.
Malacco E; Fogari R; Tettamanti F; Magenta M
J Hypertens Suppl; 1991 Dec; 9(6):S372-3. PubMed ID: 1840198
[No Abstract] [Full Text] [Related]
2. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine in the treatment of hypertension.
Kaplan NM
Postgrad Med J; 1991; 67 Suppl 5():S15-9. PubMed ID: 1839432
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine: an effective once-daily antihypertensive agent.
Tyler HM
J Hum Hypertens; 1991 Aug; 5 Suppl 1():61-6. PubMed ID: 1834848
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, parallel, comparative evaluation of amlodipine against captopril in the monotherapeutic treatment of mild and moderate essential hypertension: interim results.
Velasco M; Hernández R; Urbina A; Hernández O; Guevara J
Postgrad Med J; 1991; 67 Suppl 5():S32-4. PubMed ID: 1839436
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine with enalapril therapy in moderate-severe essential hypertension.
Jensen H; Garsdal P; Davies J
J Hum Hypertens; 1990 Oct; 4(5):541-5. PubMed ID: 2149389
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
[TBL] [Abstract][Full Text] [Related]
10. Acute, chronic and postwithdrawal antihypertensive and renal effects of amlodipine in hypertensive patients.
Leonetti G; Rupoli L; Chianca R; Catarrasi C; Ruffilli MP; Zanchetti A
J Hypertens Suppl; 1991 Dec; 9(6):S394-5. PubMed ID: 1840201
[No Abstract] [Full Text] [Related]
11. [Comparative assessment of a calcium antagonist with controlled release of nifedipine and enalapril in arterial hypertension in subjects older than 60 years].
Oleĭnikov VE; Grishaeva EE; Borisova NA; Iastrebova EI; Fadeeva SS
Kardiologiia; 2009; 49(5):34-9. PubMed ID: 19463133
[TBL] [Abstract][Full Text] [Related]
12. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
13. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
15. [Spirapril in patients with hypertension: clinical experience in Germany].
Schmidt J; Kraul H
Ter Arkh; 2000; 72(10):90-4. PubMed ID: 11220889
[TBL] [Abstract][Full Text] [Related]
16. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
17. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
19. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring.
Granberry MC; Gardner SF; Schneider EF; Carter IR
Pharmacotherapy; 1996; 16(5):932-6. PubMed ID: 8888089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
